Breakthrough innovative rapid 3D bioprinting technology Roll Porous Scaffold

Problem and implemented solution

1) Parallel testing of new substances not on animals, but using generated 3D biomodels “organ on a chip” 2) Personalized medicine with simultaneous testing of multiple treatment methods and drugs, targeted therapy for a specific patient in vitro on the 3D composition of his personal cells and selection of the most effective with the lowest toxicity 3) Overcoming the shortage of organs for implantation and personal hormone replacement therapy for everyone using printed endocrine glands from their cells

Russia
Nomination

Biotechnology And National Health

Topic

Technologies for human health

Estimated duration of implementation

12 months (1year)

Implementation geography

Ulan-Ude, Buryatia, Russia

Description of competitive advantages

Roll Porous Scaffold fast 3D bioprinting technology is orders of magnitude superior to analogues Simultaneous printing of >10 cell types (collagen and elastin, blood vessels, nerves and other tissues) Size >10-15 microns Density ~>1.26×10^8 cells/ml Layer thickness ~18 microns Productivity >1.7 l/hour

List of awards and prizes, media articles about the organization/individual or the Practice

https://www.scopus.com/authid/detail.uri?authorId=56536940900

List of scientific works and IP connected with the Practice

N.A.

Contacts

For queries about BRICS Solutions Awards please reach out to Agency for Strategic Initiatives International Office Team:

Partners

logo-ntilogo-tpprflogo-brics-businesslogo-tv-bricslogo-development-corporation
rainbow
footer-star